Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.07 USD | -7.59% | -14.81% | -31.23% |
06-24 | Omega Therapeutics, Inc. Appoints Richard N. Kender to Board of Directors | CI |
06-18 | Raymond James Initiates Omega Therapeutics at Outperform Rating With $12 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.23% | 114M | |
+19.41% | 45.51B | |
+38.65% | 38.13B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- OMGA Stock
- News Omega Therapeutics, Inc.
- Raymond James Initiates Omega Therapeutics at Outperform Rating With $12 Price Target